explore -WSS

explore

author：leisure time 2025-09-28 19:19:13 - browse：8198

Miniature people figurines standing in a group looking down. -- health tech coverage from STAT — Adobe

In less than two years, digital health’s high-flying class of public debuts have landed with a resounding thud.

Accelerated by the pandemic’s forced adoption of telehealth and other digital health solutions, 2021 saw more than 30 health technology startups go public, raising hundreds of millions and in some cases billions of dollars. Today, three members of the class of 2021 have gone bankrupt. Twelve companies have lost more than 90% of their initial value, including Bright Health Group, Cue Health, and Better Therapeutics. And dangerously low reserves have inspired desperate moves to slash costs, drum up liquidity, and find buyers.

Most recently, the bankruptcy of digital primary care company Babylon Health has drawn attention to the plight of newly-public health tech companies, and how the froth of dealmaking at the height of the pandemic led to overblown valuations. Before its debut in June 2021, Babylon was valued at $4.2 billion; after filing for bankruptcy in August, its U.K. telemedicine business was sold for just over $600,000.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

WSS

New Ultima Genomics DNA sequencer can read genome for $100

Readout Newsletter: Novo Nordisk trial, Verve base editing, etc

Cybersecurity threat forces Lurie Children's to take systems offline

Type 2 diabetes prevention programs work at large scale: study

NIH chief: government has fallen behind pharma on clinical trials

New Ultima Genomics DNA sequencer can read genome for $100

hotspot

explore

entertainment

Drug repurposing or repositioning? The language matters

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

The high cost of giving birth even with insurance

After decades in use, heart stents finally beat placebo

Psychedelics group wrestles with new pharma identity

In a test for AI, buzzy startup Insitro inks drug discovery deal with Gilead

Medicare details structure of new drug price negotiation program

CVS, Rite Aid closures threaten to worsen pharmacy deserts

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Experimental asthma app from Apple and Anthem shows promise

hotspot

The real point of Kenneth Smith’s execution by nitrogen gas

The lessons of Aduhelm, an Alzheimer's drug that was not to be

General Catalyst, Summa Health deal will turn on physician buy

White House drug czar issues call for 'recovery

Juul spent big to court Black leaders to promote its e

Ventyx halts psoriasis drug development after lackluster trial results

focus

focus

hotspot

hotspot